首页|近红外二区荧光成像在肿瘤诊疗中的研究进展

近红外二区荧光成像在肿瘤诊疗中的研究进展

扫码查看
近红外光(NIR)根据其波长可分为NIR-Ⅰ(650~900 nm)和NIR-Ⅱ(900~1 700 nm).相较于传统的NIR-Ⅰ荧光成像,NIR-Ⅱ荧光成像的组织吸收和光子散射值更低,组织穿透性和分辨率更高,是目前临床应用中最有前景的1种光学成像技术.此外,结合多模态或诊疗一体化分子探针,NIR-Ⅱ荧光成像可以实现对肿瘤的精准定位及引导治疗,对肿瘤的早期诊疗具有重要意义.该文就NIR-Ⅱ荧光成像技术在肿瘤诊断、监测转移以及治疗方面应用的研究进展进行综述.
Research progress of near-infrared Ⅱ fluorescence imaging in the diagnosis and treatment of tumors
Near-infrared(NIR)can be divided into MR-Ⅰ(650-900 nm)and MR-Ⅱ(900-1 700 nm)according to its wavelength.Compared with traditional NIR-Ⅰ fluorescence imaging,NIR-Ⅱ fluorescence imaging has lower tissue absorption and photon scattering as well as higher tissue penetration and resolution,which is considered as the most promising optical imaging technique in clinical application.In addition,combined with multimodal or therapeutic integrated molecular probes,NIR-Ⅱ fluorescence imaging can ac-curately localize tumors and guide treatment,providing a remarkable modality for early diagnosis and treat-ment of tumors.In this review,research progress on NIR-Ⅱ fluorescence imaging in the diagnosis,monito-ring of metastasis and treatment of tumors are mainly introduced.

NeoplasmsOptical imagingFluorescenceTrends

桂斌、姜楠、邓倾

展开 >

武汉大学人民医院超声影像科,武汉 430060

肿瘤 光学成像 荧光 发展趋势

国家自然科学基金国家自然科学基金

8190175982102045

2024

中华核医学与分子影像杂志
中华医学会

中华核医学与分子影像杂志

CSTPCD北大核心
影响因子:1.107
ISSN:2095-2848
年,卷(期):2024.44(2)
  • 29